Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
LIVN · Nasdaq · United States · Electromedical & Electrotherapeutic Apparatus
In shortLivaNova PLC is loss-making, generates cash and holds more cash than debt, with revenue growing (+10.7% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 14.4% | 65/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -17.5% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -19.2% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 10.0% | 67/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.36× | 47/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.31× | 94/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 4.05× | 24/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 0.72 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 12.5% | 70/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 5 | 40/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 5.6% | 90/100 |
| Operating margin volatility | 9.7% | 21/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 10.8% | 76/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 1,035 | 1,022 | 1,154 | 1,253 | 1,388 |
| Cost of revenue | 329 | 315 | 398 | 400 | 448 |
| Gross profit | 706 | 707 | 756 | 853 | 940 |
| Research & development | 183 | 156 | 194 | 183 | 186 |
| Selling, general & admin | 472 | 469 | 503 | 509 | 549 |
| Operating income | (0.8) | (77) | (68) | 129 | 199 |
| Interest expense | 50 | 48 | 59 | 63 | 49 |
| Pre-tax income | (124) | (75) | (81) | 88 | (221) |
| Income tax | 11 | 11 | (99) | 25 | 22 |
| Net income | (136) | (86) | 18 | 63 | (242) |
| Diluted EPS | −$2.68 | −$1.61 | $0.32 | $1.16 | −$4.45 |
| Diluted shares (millions) | 51 | 53 | 54 | 55 | 55 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of LivaNova PLC are included in the Investor plan. Try free for 7 days →
0.72 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026